Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Tychan Begins Phase I Trials For First Ever Yellow Fever Drug
LPNEWS

Tychan Begins Phase I Trials For First Ever Yellow Fever Drug

by prnewswire.com posted 10months ago 58 views
SINGAPORE, Dec. 6, 2018 /PRNewswire/ -- Tychan, a clinical-stage biotechnology company based in Singapore, announced today that its first-in-class candidate drug for the treatment of Yellow Fever received investigatory new drug (IND) regulatory approval from Health Sciences Authority...

In this article